Can CALM Sustain Elevated Sales Volumes in the Coming Quarters?

Cal-Maine Foods (CALM) reported strong Q3 fiscal 2025 results, with shell egg sales volumes up 10.2% year-over-year to 331.4 million dozen, driven by seasonal demand and weather-related consumer stockpiling; year-to-date sales are up 17% to 971.2 million dozen. The company is expanding capacity and investing in biosecurity, while competitors Vital Farms (VITL) and Post Holdings (POST) also reported volume increases, though CALM's stock has underperformed the industry year-to-date and faces a projected earnings decline in fiscal 2026 after a significant increase in fiscal 2025.

Analysis

Cal-Maine Foods (CALM) demonstrated robust operational performance in its third quarter of fiscal 2025, reporting a 10.2% year-over-year increase in shell egg sales to a record 331.4 million dozen, driven by strong seasonal demand and consumer stockpiling due to severe weather. Year-to-date sales volumes have surged 17% to 971.2 million dozen, reflecting consistent growth with Q1 volumes up 13% and Q2 up 10%. The company's ongoing capacity expansion projects, aiming to add approximately 1.1 million cage-free layer hens and 250,000 pullets this year, plus an additional 1.2 million free-range hens by calendar year-end through its Dexter, MO facility, are set to support future production. Investments in biosecurity are also crucial for mitigating avian flu risks. Despite these strong volume metrics and bullish industry demand, evidenced by volume growth at competitors Vital Farms (VITL) and Post Holdings (POST), CALM's stock has underperformed, declining 7.7% year-to-date against an industry dip of 4.7%. The company trades at a forward P/E of 16.61x, significantly above the industry average of 10.43x. Critically, while fiscal 2025 earnings per share are estimated to surge by 299.5% to $22.73, a sharp decline of 74.9% to $5.71 is projected for fiscal 2026, suggesting the current earnings uplift may be transient. This outlook is underscored by a Zacks Rank #4 (Sell) and a negative sentiment score of -0.3 for the stock.

Key Decisions for Investors

• Investors should acknowledge Cal-Maine Foods' strong current sales volumes and capacity expansion initiatives, but exercise caution due to the stock's premium valuation relative to the industry and the significant earnings decline projected for fiscal 2026.
• Monitor avian influenza developments and the effectiveness of CALM's biosecurity measures, as these are critical risk factors for production stability and future earnings consistency.
• Given the stock's year-to-date underperformance despite operational strength, the Zacks Rank #4 (Sell), and the anticipated sharp drop in earnings for fiscal 2026, a review of existing positions and a cautious approach to new investments may be warranted until a more sustainable earnings trajectory is evident.